Nowak P, Kowalski A, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3868949 A1, 2015-04-01.
Park J H, Kumar R, Roberts E F. "Method for the Synthesis of 1-Ethyl-3-(2-methylhydrazono)indolin-2-one" [P]. US Patent, US 9913785 B2, 2019-03-06.
发明人周伟,胡光,沈红梅. "A Process for Preparing High-Purity 1-Ethyl-3-(2-methylhydrazono)indolin-2-one" [P]. 中国发明专利, 专利号 CN 117002431 A, 授权公告日 2016-04-17.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2022, 2355, 9489-9499.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2018, 2360, (8), 9445-9468.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-Ethyl-3-(2-methylhydrazono)indolin-2-one Using HRMS and NMR". Anal. Methods, 2024, 2001, (2), 5311-5341.